2026-01-29 - Analysis Report
**Align Technology (ALGN) Financial Report**

### Stock Overview
Align Technology is a global medical device company that designs, manufactures, and markets a wide range of dental and orthodontic products, including clear aligners and other devices.

### Return Rate Comparison
* Cumulative return of review stock (ALGN): -16.68%
* Cumulative return of comparison stock (S&P 500, VOO): 128.51%
* Divergence: -145.20 (relative divergence: 4.20%)

The ALGN stock has underperformed the S&P 500, with a cumulative return of -16.68% compared to 128.51% for the S&P 500.

### Multi-Year Performance
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|--------|
| 2016-2018  | 65.0% | 48.7% | 57.0% | 1.5  | 15.0B  |
| 2017-2019  | 79.0% | 51.1% | 54.0% | 1.6  | 20.0B  |
| 2018-2020  | 81.0% | 56.9% | 58.0% | 1.5  | 38.3B  |
| 2019-2021  | 166.0% | 53.3% | 101.0% | 1.5  | 47.1B  |
| 2020-2022  | -70.0% | 73.3% | -74.0% | 1.5  | 15.1B  |
| 2021-2023  | -195.0% | 73.3% | -213.0% | 1.7  | 19.6B  |
| 2022-2024  | -169.0% | 65.1% | -198.0% | 1.7  | 14.9B  |
| 2023-2025  | -62.0% | 60.0% | -138.0% | 1.5  | 11.2B  |

The company's multi-year CAGR (Compound Annual Growth Rate) has been volatile, with a high of 166.0% in 2019-2021 and a low of -195.0% in 2021-2023.

### Stock Price Fluctuation
* Close: $167.04
* Last-market: $165.275
* 5-day SMA: $168.46
* 20-day SMA: $166.42
* 60-day SMA: $154.33

The short-term stock price has been trending downwards, with a 5-day SMA and 20-day SMA both below the current price.

### RSI, PPO, and Delta_Previous_Relative_Divergence
* Market Risk Indicator (MRI): 0.70
* RSI: 48.80
* PPO: -0.50
* Hybrid Signal: Buy
* Recent (20 days) relative divergence change: -1.30 (-)
* 7-day Rank change: 11 (+)
* 7-day Dynamic Expected Return change: 480.00 (+)
* Expected Return (%): -1028.30%

The company's MRI is at 0.70, indicating a medium-risk investment. The RSI is at 48.80, indicating that the stock is oversold. The PPO is at -0.50, indicating a sell signal.

### Recent News & Significant Events
* 2026-01-28: Align Technology (ALGN) Reports Next Week: Wall Street Expects Earnings Growth
* 2026-01-26: How Investors Are Reacting To Align Technology (ALGN) Margin Roadmap and New 0x3 Treatment Suite
* 2025-10-30: ALGN Stock Up on Q3 Earnings and Revenue Beat, Margins Crash
* 2026-01-19: Align Technology Q4 Preview: Even After A Big Drop In Price, Itâ€™s Too Expensive (ALGN)
* 2026-01-23: Piper Sandler reiterates Overweight rating on Align Technology stock
* 2025-10-30: Why Align Technology Stock Popped Today

### Analyst Opinions
```text
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.17 (~Buy)
- Opinions: 15
- Target Price (avg/high/low): 183.87 / 220.00 / 150.00
```

### Recent Earnings Analysis
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-11-05 | 0.78 | 1.00 B$ |
| 2025-08-06 | 1.72 | 1.01 B$ |
| 2025-05-08 | 1.27 | 0.98 B$ |
| 2024-11-05 | 1.55 | 0.98 B$ |
| 2025-11-05 | 1.55 | 0.98 B$ |

The company's EPS (Earnings Per Share) has been volatile, with a high of 1.72 in 2025-08-06 and a low of 0.78 in 2025-11-05. The revenue has been stable, with an average of $1.00B.

### Revenue and Profitability
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.00B | 64.20% |
| 2025-06-30 | $1.01B | 69.94% |
| 2025-03-31 | $0.98B | 69.45% |
| 2024-12-31 | $1.00B | 70.03% |
| 2024-09-30 | $0.98B | 69.72% |

The company's revenue has been stable, with an average of $1.00B. The profit margin has fluctuated, with a high of 70.03% in 2024-12-31 and a low of 64.20% in 2025-09-30.

### Capital and Profitability
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $3.96B | 1.43% |
| 2025-06-30 | $3.91B | 3.18% |
| 2025-03-31 | $3.79B | 2.46% |
| 2024-12-31 | $3.85B | 2.69% |
| 2024-09-30 | $3.94B | 2.94% |

The company's equity has fluctuated, with a high of $3.96B in 2025-09-30 and a low of $3.79B in 2025-03-31. The ROE (Return on Equity) has fluctuated, with a high of 3.18% in 2025-06-30 and a low of 1.43% in 2025-09-30.

### Comprehensive Analysis (Summary of previous items)
The company's stock price has been trending downwards, with a 5-day SMA and 20-day SMA both below the current price. The RSI is at 48.80, indicating that the stock is oversold. The PPO is at -0.50, indicating a sell signal. The company's MRI is at 0.70, indicating a medium-risk investment. The recent news and significant events indicate a potential earnings growth and a high target price from analysts. However, the company's EPS and revenue have been volatile, and the profit margin has fluctuated. The equity and ROE have also fluctuated.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.